Jeil Pharmaceutical

271980-KR:KRX

Pharmaceuticals: Major

Market Cap

—

SMALL cap

Share Price ←

(—)

YTD Return ←

—

since start of 2020

P/E Ratio

—

Corporate Values

Carbon Footprint
Pollution Prevention
Water Conservation
Data & Privacy Protection
Consumer Health, Wellness & Safety
Employee Ownership, Satisfaction, Benefits & Pay
Workplace Health and Safety
Integrity of Corporate Governance
Ethical Practices
Usage of Conflict Materials
Forced Labor
Diversity of Corporate Leadership

About

Pharmaceuticals: Major Founded 2017

Jeil Pharmaceutical Co., Ltd. engages in developing pharmaceuticals. It provides drugs for Antibiotic, Oncology, Cardiovascular, Gatrointestinal, Neuropsychiatry, Urology, Endocrinology, Respiratory, Antiviral, Musculoskeletal and other divisions. The company was founded on June 1, 2017 and is headquartered in Seoul, South Korea.

website

Headquarters

Seocho-gu

343 Sapyeong-daero

Seoul 06543

82.2.549.7451

Executives

Name	Title	Gender

Mindful Investing Summary

Carbon Footprint

— N/A
Pollution Prevention

— N/A
Water Conservation

— N/A
Data & Privacy Protection

— N/A
Consumer Health, Wellness & Safety

— N/A
Employee Ownership, Satisfaction, Benefits & Pay

— N/A
Workplace Health and Safety

— N/A
Integrity of Corporate Governance

— N/A
Ethical Practices

— N/A
Usage of Conflict Materials

— N/A
Forced Labor

— N/A
Diversity of Corporate Leadership

— N/A

Jeil Pharmaceutical - Competitors and Related Companies

How Jeil Pharmaceutical stacks up to its peers in the Pharmaceuticals: Major industry or with competing business segments.